Doxorubicin Directs the Accumulation of Interleukin-12–Induced IFNγ into Tumors for Enhancing STAT1–Dependent Antitumor Effect
Open Access
- 15 July 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (14) , 4252-4260
- https://doi.org/10.1158/1078-0432.ccr-06-2894
Abstract
Purpose: To examine the mechanism by which doxorubicin plus interleukin-12 (IL-12) gene transfer induces enhanced therapeutic efficacy against tumors.Keywords
This publication has 35 references indexed in Scilit:
- Administration Route- and Immune Cell Activation-Dependent Tumor Eradication by IL12 electrotransferMolecular Therapy, 2005
- Crucial Role for Interferon γ in the Synergism between Tumor Vasculature-Targeted Tumor Necrosis Factor α (NGR-TNF) and DoxorubicinCancer Research, 2004
- Candidate Genes Associated with Tumor Regression Mediated by Intratumoral Il-12 Electroporation Gene TherapyMolecular Therapy, 2004
- Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA arrayGene Therapy, 2002
- Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant siteCancer Gene Therapy, 2001
- Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant siteGene Therapy, 2001
- Interleukin-12 (IL-12) gene therapy of leukemia: Immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cellsCancer Gene Therapy, 2000
- Antitumoral vaccination with granulocyte-macrophage colony-stimulating factor or interleukin-12-expressing DHD/K12 colon adenocarcinoma cellsCancer Gene Therapy, 2000
- Efficient cotransduction of tumors by multiple herpes simplex vectors: Implications for tumor vaccine productionCancer Gene Therapy, 2000
- Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in ratsJournal of Neurosurgery, 2000